The antibody-based pharmaceuticals resource library’s Podcast

Design and Production of Newcastle Disease Virus for Intratumoral Immunomodulation

Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.

A Functional Assay to Determine the Capacity of Oncolytic Viruses to Induce Immunogenic Tumor Cell Death

Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.

Tumor TargetingIntroduction of Oncolytic Adenovirus and the Three Retargeting Strategies

Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.

The Method to Get Soluble Coxsackie and Adenovirus Receptor Bispecific Adapter Proteins

Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.

Immunomodulation in Oncolytic Measles Virotherapy-Ⅲ

Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.

Immunomodulation in Oncolytic Measles Virotherapy-Ⅱ

Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.

Immunomodulation in Oncolytic Measles Virotherapy-Ⅰ

Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.

Ep.4 Multiple Aspects of T Cell Receptors-Gene-Modified T Cells for Cancer

This episode focuses on various aspects of TCR-engineered T-cell therapy, such as risks, clinical trials, and comparison between TCR-engineered T cells and CAR-T cells.

Ep.3 CAR-T Cells for Leukemias in Adults

This episode focuses on the clinical outcomes in adult leukemia patients treated with CAR-T cells, current challenges limiting the efficacy, and future research directions.

Ep.2 CAR-T Cells for Leukemias in Children

Leukemia remains the leading cause of death from childhood cancer. This episode focuses on how CAR-T cell therapy brings hope to childhood leukemia patients.